KESTRA MEDICAL TECHNOLOGIES (KMTS) Stock Analyst Ratings
USA - NASDAQ:KMTS - BMG524411052 - Common Stock
26.22 USD
+0.12 (+0.46%)
26.22 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 85% to KMTS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 27.71. This target is 5.68% above the current price.
KMTS was analyzed by 12 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about KMTS.
In the previous month the buy percentage consensus was at a similar level.
KMTS was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-07-17 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-04-16 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-03-31 | Wolfe Research | Initiate | Outperform |
| 2025-03-31 | Stifel | Initiate | Buy |
| 2025-03-31 | Wells Fargo | Initiate | Overweight |
| 2025-03-31 | Goldman Sachs | Initiate | Neutral |
| 2025-03-31 | Piper Sandler | Initiate | Overweight |
KESTRA MEDICAL TECHNOLOGIES / KMTS FAQ
What is the average price target for KESTRA MEDICAL TECHNOLOGIES (KMTS) stock?
12 analysts have analysed KMTS and the average price target is 27.71 USD. This implies a price increase of 5.68% is expected in the next year compared to the current price of 26.22.
Can you provide the consensus rating for KESTRA MEDICAL TECHNOLOGIES stock?
The consensus rating for KESTRA MEDICAL TECHNOLOGIES (KMTS) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.